CP
Corvus Pharmaceuticals Inc
🇩🇪XFRA.C17GermanyHealthcare
€10.83EURdown -0.41 (-3.65%)OpenEnd of day9:12 AM
Price€10.83-0.41 (-3.65%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US2210151005
- CUSIP
- Not reported
Company
- Employees
- 37
- Headquarters
- South San Francisco, United States
- Website
- https://www.corvuspharma.com
- CEO
- Dr. Richard A. Miller M.D.
Market
- Shares outstanding
- 74.7M
- Market cap
- €808.8M
Highlights
No high and low reported for today's session.
- Market cap
- €808.8M
- EPS LTM
- -$0.59
- P/E LTM
- -24.83
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$54.13M-19.93%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$45.23M-56.09%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.